Table 4.
Cardiovascular measures
| Time, min |
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| 0 | 15 | 30 | 45 | 60 | 75 | 90 | 105 | 120 | |
| HR, beats/min | |||||||||
| Baseline | 72 ± 3 | 74 ± 3 | 77 ± 3 | 76 ± 3 | 75 ± 4 | 75 ± 3 | 75 ± 3 | 76 ± 3 | 78 ± 3 |
| 7-day Exercise | 68 ± 3 | 72 ± 3 | 71 ± 3 | 72 ± 3 | 72 ± 3 | 72 ± 3 | 72 ± 3 | 72 ± 3 | 73 ± 3 |
| MAP, mmHg | |||||||||
| Baseline | 90 ± 1 | 88 ± 1 | 87 ± 2 | 87 ± 2 | 87 ± 2 | 87 ± 2 | 86 ± 2 | 86 ± 2 | 87 ± 2 |
| 7-day Exercise | 87 ± 2 | 88 ± 3 | 86 ± 3 | 86 ± 2 | 85 ± 2 | 86 ± 3 | 86 ± 3 | 86 ± 3 | 85 ± 3 |
Data are expressed as means ± SE. Cardiovascular responses to the oral glucose tolerance test at baseline and following the 7-day aerobic exercise program.HR, heart rate; MAP, mean arterial pressure.